The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
Aug 8, 2026
· 14 min read
Quick Score
○ Unverifiable
View full audit trail →
The Ozempic era is bringing fatphobia back – and dividing my community
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.299 · RIGHT
Ensemble
0.149 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.091
9,559 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
OPINION
A fork in the road
Affordable generic weight-loss drugs are sparking a resurgence of fatphobia, leaving my community divided and isolated
LAYLA CAMERON
THE GLOBE AND MAIL
PUBLISHED 58 MINUTES AGO
In the last 10 years it felt like fat positivity was finally having its moment, writes Layla Cameron. But with the popularization of GLP-1 drugs, that progress is rolling back.
CARMIN KÕVAMEES/SUPPLIED
2 COMMENTS
SHARE
SAVE FOR LATER
Layla Cameron is an academic, writer and documentary filmmaker.
I don’t know a single fat person who has not fantasized about losing weight at some point in t…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.